Adalimumab (Humira) approved by NICE for NHS use

Adalimumab (Humira) has been approved by NICE for NHS use in the UK for people with active moderate to severe Hidradentitis.

This comes after the medicine was approved for use in the EU in 2015.

The NHS will pay a reduced price for the drugs after a discount was agreed between the company and the Department of Health.

Leave a Comment

Your email address will not be published. Required fields are marked *